Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617

Authors

Lei Peng, Yale University
Yingxia Hu, Yale University
Madeleine C Mankowski, Yale University
Ping Ren, Yale University
Rita E Chen, Washington University School of Medicine in St. Louis
Michael S Diamond, Washington University School of Medicine in St. Louis
et al

Journal

Nature Communications

Publication Date

3-28-2022

Volume

13

Issue

1

First Page

1638

Document Type

Open Access Publication

DOI

10.1038/s41467-022-29288-3

Rights and Permissions

Peng, L., Hu, Y., Mankowski, M.C. et al. Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617. Nat Commun 13, 1638 (2022). doi.org/10.1038/s41467-022-29288-3 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Recommended Citation

Peng, Lei; Hu, Yingxia; Mankowski, Madeleine C; Ren, Ping; Chen, Rita E; Diamond, Michael S; and et al, "Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617." Nature Communications. 13, 1. 1638 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11710